Jan Buckner, MD

Jan Buckner, MD

Oncology Rochester, MN

Professor of Medicine, Mayo Medical School

Office Address

  • 200 1st St Sw
    Mayo Clinic
    Rochester, MN 55905
    Phone: (507) 284-2511

Jan Buckner, MD

Oncology Rochester, MN

Professor of Medicine, Mayo Medical School

Clinical Specialties & Interests

  • Neuro-Oncology
  • Clinical Interests: Controlled Clinical Trials as Topic

Education & Training

  • Mayo School of Graduate Medical EducationMayo School of Graduate Medical Education
  • Spectrum Health-Butterworth Campus
  • University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina at Chapel Hill School of Medicine
  • Wake Forest UniversityWake Forest University

Certifications & Licensure

  • MN State Medical LicenseMN State Medical License1983 - 2016
  • American Board of Internal MedicineMedical Oncology
  • American Board of Internal MedicineInternal Medicine

    Awards, Honors, & Recognition

    • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009
    • America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005
    • Best Doctors/Medical OncologyBest Doctors in America, 2011-2013

    Clinical Trials

    Publications & Presentations


    Journal Articles

    • Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02  Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP, J Clin Oncol, 1/13/2014
    • Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH  Cairncross JG, Wang M, Jenkins RB, Shaw EG, Giannini C, Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ, Huse JT, Mehta MP, Curran WJ Jr, J Clin Oncol, 1/10/2014
    • Physician Perspective on Incorporation of Oncology Patient Quality-of-Life, Fatigue, and Pain Assessment Into Clinical Practice  Hubbard JM, Grothey AF, McWilliams RR, Buckner JC, Sloan JA, J Oncol Pract, 1/5/2014

    Books/Book Chapters

    • Brain Tumors Chapter: Esthesioneuroblastoma: management and outcome. Page 767 - 778
      Fogelson JL, Link MJ, Olsen KD, Moore EJ, Giannini C, Foote RL, Buckner JC
      Editors: .
    • Primary Central Nervous System Tumors Pathogenesis and Therapy Chapter: Complications of Therapy. Page 103 - 141
      Johnson D, Ashman J, Brown P, Lachance DH, Buckner JC
      Editors: Nordan A, Reardon D, Wen P.Humana Press, New York, NY
    • DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology Chapter: Neoplasms of the central nervous system. Page 1975 - 2032
      Mehta MP, Buckner J, Sawaya RP, Cannon GM
      Editors: DeVita VT Jr. Lawrence TS, Rosenberg SA.Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia
      Edition 8th,2008


    • RTOG 9802: Phase III Study of Radiation Therapy (RT) with or without Procarbazine, CCNU, and Vincristine (PCV) in Low-Grade Glioma. Jan C. Buckner, MD, NRG Oncology Semi-Annual Meeting, Chicago, IL, 1/11/2014
    • Standardizing measurement of tobacco use in cancer clinical trials. Land SR, Toll B, Warren GW, Brandon TH, Mitchell SA, Dresler CM, Gritz ER, Schnoll R, Sarna L, Moinpour C, Ostroff JS, Khuri FR, Buckner JC, Cummings KM, Herbst RS, Sh..., J Clin Oncol, 1/1/2014
    • Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Singh JA, Locke DE, Satele D, Puttabasavaiah S, Buckner JC, Sloan JA, J Clin Oncol, 1/1/2014


    • "Update in Neuro-Oncology" Minneapolis, MN - 1/26/2014
    • Update on management of grade II and III glioma. Sydney, Australia - 1/25/2013
    • The Role of Angiogenesis Inhibitors in Clinical Neuro-Oncology. Sydney, Australia - 1/25/2013


    • Classification and regression tree (CART) models of time to progression and overall survival in patients with recurrent glioma. Buckner JC, Novotny P, Schaefer P, O'Fallon JR
    • Safety of thrice daily hyperfractionated radiation and BCNU for high grade glioma. Rao RD, Thome S, O'Fallon JR, Earle JD, Dinapoli RP, Buckner JC
    • Technology assessment report: blood brain barrier disruption chemotherapy. Moynihan T, Buckner JC, Hall W, Wilkowske M, Institute for Clinical Systems Integration

    Grant Support

    • North Central Cancer Treatment Group (NCCTG) Biospecimen ResourceNational Cancer Institute
      2011 - 2012
    • Ncctg Biospecimen ResourceNational Cancer Institute
      2005 - 2011
    • Phase 1b/Ii Trial Of CPT-11 And Radiation Followed By CPT-11 And BCNUNational Center For Research Resources
      2005 - 2005
    • Ncctg - Foreign AccrualNational Cancer Institute
      2005 - 2005
    • Phase 1/Ii Trial Of Cpt-11/Radiation With CPT-11 &BcnuNational Center For Research Resources
      2004 - 2004
    • Core--Clinical Research FacilityNational Cancer Institute
      2004 - 2008
    • Ncctg Foreign AccrualNational Cancer Institute
      2004 - 2004
    • Core--Clinical Research OfficeNational Cancer Institute
      2004 - 2008
    • North Central Cancer Treatment GroupNational Cancer Institute
      2004 - 2012
    • Ncctg Foreign AccrualNational Cancer Institute
      2003 - 2003
    • North Central Cancer Treatment GroupNational Cancer Institute
      2002 - 2003
    • NeurooncologyNational Cancer Institute
      2001 - 2002
    • Data MonitoringNational Cancer Institute
      2001 - 2002
    • Intravenous CCI 799 Given To Patients W/ Advanced Solid TumorsNational Center For Research Resources
      1999 - 2002
    • Phase II Trial Of DTIC In GliomaNational Center For Research Resources
      1997 - 1999

    Professional Memberships

    Hospital Affiliations

    Insurance Accepted

    • Aetna Choice POS II
    • Aetna HMO
    • BCBS Blue Card PPO
    • BCBS Illinois PPO
    • CareFirst BCBS Maryland POS
    • CareFirst BlueChoice Advantage
    • CareFirst BlueChoice Network POS
    • CareFirst BluePreferred PPO
    • CIGNA Open Access
    • First Choice
    • First Health PPO
    • Great West PPO
    • Humana ChoiceCare Network PPO
    • Multiplan PHCS PPO
    • Multiplan PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO
    • WEA Trust Preferred Provider Plan - Trust Pref
    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Buckner's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV